These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23358478)

  • 1. Myocardial radionuclide imaging in patients with hypertrophic cardiomyopathy.
    Cai M; Tian YQ; He ZX
    Nucl Med Commun; 2013 Apr; 34(4):298-305. PubMed ID: 23358478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial condition after transcoronary ablation predicts the curative effect in patients with hypertrophic obstructive cardiomyopathy.
    Jiang TY; Wu XS; Han ZH; Jia CQ; Mi HZ; Gao YC; Zhang XL
    Chin Med J (Engl); 2006 Feb; 119(3):246-9. PubMed ID: 16537015
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of cardiac magnetic resonance imaging for alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Batton K; Moussa I; Blackshear J; Mergo P; Austin C; Shapiro B
    Acute Card Care; 2013 Jun; 15(2):44-6. PubMed ID: 23663012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
    Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
    Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in familial hypertrophic cardiomyopathy associated with abnormal thallium perfusion and cardiac enzymes.
    Nishimura T; Nagata S; Sakakibara H
    Jpn Circ J; 1988 May; 52(5):395-400. PubMed ID: 3411762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial perfusion and metabolism after transcoronary ablation of septum hypertrophy (TASH) in hypertrophic obstructive cardiomyopathy.
    Lerch H; Schäfers M; Gietzen F; Schäfers K; Kuwert T; Kuhn H; Schober O
    Nuklearmedizin; 1997 Sep; 36(6):218-22. PubMed ID: 9380540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol septal ablation in hypertrophic cardiomyopathy: an opportunity to be taken.
    Gimeno JR; Tomé MT; McKenna WJ
    Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):314-8. PubMed ID: 22381943
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Okayama S; Uemura S; Soeda T; Horii M; Saito Y
    J Cardiovasc Comput Tomogr; 2010; 4(1):62-5. PubMed ID: 19914881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing improvement of cardiac sympathetic activity on I-123 MIBG scintigraphy in a patient with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
    Okayama S; Uemura S; Horii M; Kawata H; Saito Y
    J Nucl Cardiol; 2008; 15(5):e31-4. PubMed ID: 18761260
    [No Abstract]   [Full Text] [Related]  

  • 10. [Asymmetric septal hypertrophy of sporadic form with abnormal thallium perfusion and myocardial enzymes].
    Nagata S; Minamikawa T; Park YD; Nishimura T; Yutani C; Ohmori F; Sakakibara H; Nimura Y
    J Cardiogr Suppl; 1986; (9):57-65. PubMed ID: 3760618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of left ventricular myocardial perfusion and function using gated SPECT in patients with hypertrophic obstruction cardiomyopathy following percutaneous transluminal septal myocardial ablation.
    Zhang L; Liu R; Qiao SB; Sun XX; He ZX; Tian YQ
    Nucl Med Commun; 2014 Jul; 35(7):762-6. PubMed ID: 24681766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Protruding Myocardium" as a Target for Percutaneous Transluminal Septal Myocardial Ablation in a Case of Hypertrophic Obstructive Cardiomyopathy.
    Maekawa Y; Akita K; Tsuruta H; Yashima F; Kimura M; Yamada Y; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Murata M; Jinzaki M; Fukuda K
    JACC Cardiovasc Interv; 2015 Oct; 8(12):e201-2. PubMed ID: 26493263
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical use of metaiodobenzylguanidine imaging in cardiology.
    Merlet P; Piot O; Dubois-Randé JL; Loisance D; Castaigne A; Syrota A
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):29-39. PubMed ID: 9002746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dilated cardiomyopathy. Role of radioisotope technics].
    Cuocolo A; McCarthy KE; Salvatore M
    Radiol Med; 1988 May; 75(5):439-45. PubMed ID: 3163814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic hypertrophic subaortic stenosis: detection by thallium 201 myocardial perfusion imaging.
    Bulkley BH; Rouleau J; Strauss HW; Pitt B
    N Engl J Med; 1975 Nov; 293(22):1113-6. PubMed ID: 1237793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of radionuclide imaging techniques in assessing cardiomyopathy.
    Goldman MR; Boucher CA
    Am J Cardiol; 1980 Dec; 46(7):1232-6. PubMed ID: 7192931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intraprocedural CT imaging to guide alcohol septal ablation of hypertrophic cardiomyopathy in the cardiac catheterization laboratory.
    Krishnaswamy A; Tuzcu EM; Kapadia SR
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):991-4. PubMed ID: 22121082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory monitoring of aborted sudden cardiac death related to hypertrophic cardiomyopathy.
    Vaglio JC; Sorajja P; Gersh BJ
    Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):659-62; quiz following 662. PubMed ID: 16306922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy.
    Agarwal S; Puri S; Wang H
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):350-4. PubMed ID: 23992655
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.
    Pedone C; Biagini E; Galema TW; Vletter WB; ten Cate FJ
    J Am Soc Echocardiogr; 2006 Aug; 19(8):982-6. PubMed ID: 16880092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.